Figure 1

Cytotoxicity curves for human bladder cancer cell line RT112 and 4-ABP resistant clones RT5 and RT11 after the first 4-ABP treatment panel (A); after the second 4-ABP treatment, panel (B).
Cytotoxicity curves for human bladder cancer cell line RT112 and 4-ABP resistant clones RT5 and RT11 after the first 4-ABP treatment panel (A); after the second 4-ABP treatment, panel (B).